TNXP: Tonix Pharmaceuticals Holding Corp. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 15.53
Enterprise Value ($M) -0.51
Book Value ($M) 105.53
Book Value / Share 1.10
Price / Book 0.15
NCAV ($M) -1.16
NCAV / Share -0.01
Price / NCAV -13.34

Profitability (mra)
Return on Invested Capital (ROIC) -1.01
Return on Assets (ROA) -0.65
Return on Equity (ROE) -0.71

Liquidity (mrq)
Quick Ratio 1.78
Current Ratio 2.53

Balance Sheet (mrq) ($M)
Current Assets 47.77
Assets 154.46
Liabilities 48.93
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 7.77
Operating Income -118.38
Net Income -116.66
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -102.00
Cash from Investing -29.07
Cash from Financing 36.52

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G Alyeska Investment Group, L.P. 9.99
02-14 13G Armistice Capital, Llc 6.71
02-14 13G/A Tang Capital Partners Lp 0.00
01-11 13G Empery Asset Management, LP 9.99
01-03 13G Sabby Management, Llc 9.99

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-01 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One)
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One)
2023-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT P

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-12 723,026 2,365,346 30.57
2024-04-11 1,102,239 241,393 456.62
2024-04-10 1,175,775 3,422,070 34.36
2024-04-09 618,531 2,587,220 23.91
2024-04-08 990,851 3,545,391 27.95

(click for more detail)

Similar Companies
THTX – Theratechnologies Inc. TIL – Instil Bio, Inc.
TLSA – Tiziana Life Sciences Ltd TPST – Tempest Therapeutics, Inc.
TRAW – Traws Pharma, Inc.


Financial data and stock pages provided by
Fintel.io